Rao, X.; Qiao, Z.; Yang, Y.; Deng, Y.; Zhang, Z.; Yu, X.; Guo, X.
Unveiling Epigenetic Vulnerabilities in Triple-Negative Breast Cancer through 3D Organoid Drug Screening. Pharmaceuticals 2024, 17, 225.
https://doi.org/10.3390/ph17020225
AMA Style
Rao X, Qiao Z, Yang Y, Deng Y, Zhang Z, Yu X, Guo X.
Unveiling Epigenetic Vulnerabilities in Triple-Negative Breast Cancer through 3D Organoid Drug Screening. Pharmaceuticals. 2024; 17(2):225.
https://doi.org/10.3390/ph17020225
Chicago/Turabian Style
Rao, Xinxin, Zhibin Qiao, Yang Yang, Yun Deng, Zhen Zhang, Xiaoli Yu, and Xiaomao Guo.
2024. "Unveiling Epigenetic Vulnerabilities in Triple-Negative Breast Cancer through 3D Organoid Drug Screening" Pharmaceuticals 17, no. 2: 225.
https://doi.org/10.3390/ph17020225
APA Style
Rao, X., Qiao, Z., Yang, Y., Deng, Y., Zhang, Z., Yu, X., & Guo, X.
(2024). Unveiling Epigenetic Vulnerabilities in Triple-Negative Breast Cancer through 3D Organoid Drug Screening. Pharmaceuticals, 17(2), 225.
https://doi.org/10.3390/ph17020225